en.Wedoany.com Reported - Siemens Healthineers will build a new radiopharmaceutical production base in the UK, with an investment of tens of millions of dollars. Located in Dunstable, England, the facility will have a production capacity up to eight times that of other radiopharmaceutical facilities. The new facility, costing approximately $30 million, aims to provide a more reliable supply chain for local radiopharmaceuticals.
The base will be equipped with two high-energy cyclotrons, multiple cleanrooms and hot cells, dedicated distribution areas, and a large quality control laboratory. All critical equipment will have dual backups to ensure operational resilience. The location of the Dunstable base plays a key role in stabilizing the regional supply chain, enabling same-day delivery to numerous nearby PET/CT centers, thereby expanding patient access to critical diagnostic and therapeutic services.
Ghada Trotabas, Managing Director of Siemens Healthineers Great Britain and Ireland, stated that the radiopharmaceutical market is accelerating, and the supply chain cannot become a limiting factor. The company's investment in the 8X radiopharmacy, the first of its kind, offers eight times the production capacity of traditional radiopharmacies. This is not just about scale, but about resilience, reliability, and long-term supply assurance, aiming to ensure that the confidence of the UK's National Health Service (NHS) and patients in access to critical diagnostics can keep pace with growing clinical demand, both now and in the future. Josh Nutting, Managing Director of Siemens Healthineers Radiopharma International, added that the new facility represents a significant milestone. Through the Dunstable 8X facility, the company is making a long-term commitment to the UK market, strengthening its ability to supply high-quality radiopharmaceuticals at scale and preparing for the next wave of diagnostic and therapeutic innovations.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
